Regenerating the lost cardiomyocytes in Myocardial patients: FRA1 increases the expression of ERBB2 and promotes dedifferentiation of cardiomyocytes via down regulation of its target gene, 3/May/2014, 12.39 am

Indian herb Tulsi ameliorates T2DM & extends lifespan: Ursolic acid, enriched in Tulsi [OcimumSanctum Linn] and apples, increases UCP protein expression, energy expenditure, glucose tolerance, insulin sensitivity, cold exposure tolerance and extends lifespan via up regulation of its target gene, 3/May/2015, 12. 33 am
May 2, 2015
Molecular therapy for Human Cancer: Suppressor of cytokine signaling 1 (SOCS1) suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 3/May/2015, 7.53 am
May 3, 2015
Show all

A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was published in the 6 April  2015 issue of the journal “Nature cell biology” (the number 1 journal in “Cell biology” research with an impact factor of 20.761) by Prof Tzahor ED’Uva G, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Regenerating the lost cardiomyocytes in Myocardial patients: FRA1 increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down regulation of its target gene

Significance: 

Given that: (1)  cardiovascular disease is the leading cause of death worldwide; (2) in India, in 2004, 14.6 lakhs deaths (14% of total deaths) were due to ischemic heart disease; and were expected to be doubled by 2015; and (3) the global economic cost spent in the treatment of cardiovascular disease in 2011 was little more than 10 billion US dollars, there is an urgent need to find a way to induce regeneration of cardiomyocytes that were lost in Myocardial patients.

This study suggests, for the first time, that FRA1, by decreasing the expression of its target gene, it may: (1) increase ERBB2 expression; and (2) induce cardiomycyte regeneration.  Thus, pharmacological formulations encompassing “FRA1 activators” may be used to promote cardiomyocyte regeneration following myocardial infarction

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Regenerating the lost cardiomyocytes in Myocardial patients: FRA1 increases the expression of ERBB2 and promotes dedifferentiation  of cardiomyocytes via down regulation of its target gene, 3/May/2014, 12.39 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How FRA1 increases the expression of  ERBB2

Comments are closed.